Nicotine e-cigarettes legalised - Expert Reaction
29 March 2017
Associate Health Minister Nicky Wagner has announced the sale of nicotine e-cigarettes and e-liquid will be legalised.
Controls will include restricting sales to over 18-year-olds and prohibiting vaping in indoor workplaces and other areas where smoking is banned under the Smoke-free Environments Act.
The Science Media Centre gathered expert
reaction on the announcement. Associate Professor Marewa
Glover, School of Public Health, Massey University,
Associate Professor Marewa Glover, School of Public Health, Massey University, comments:
"There is unfortunate confusion with banning vaping wherever smoking is banned, which sends a mixed message that vaping must be similarly dangerous which it is not. Though Minister Wagner did say under the Smokefree Environments Act, which currently does not ban smoking in many outdoor areas.
"Local Govt Councils, District Health Boards, Universities and other workplaces are, however, being heavily lobbied to ban smoking on their grounds (which goes beyond the SFE Act) and they are banning vaping also.
"So the message is: you’ll be able to buy nicotine for vaping as an alternative to smoking but you won’t be able to vape where smoking is banned and we’re going to extend those bans to as many outdoor and public and non-public areas as we possibly can.
"For instance, Housing NZ tenants are not allowed to smoke on Housing NZ properties including residential rental properties. It’s giving with one hand, taking away with the other.
"I am concerned too about signalled restrictions on strength of nicotine in e-liquid – so there is still a lot of ignorance around vaping. "
Professor Janet Hoek, co-director ASPIRE 2025, University of Otago, comments:
"I think it is concerning that e-cigarettes will be so widely available (in dairies, service stations and supermarkets).
"A submission prepared by University of Otago and University of Auckland researchers (see here) suggested either retaining the status quo or limiting distribution to specialist vape stores and pharmacies, where smokers are more likely to get the expert advice that will promote full transition from vaping to smoking.
"The Cabinet paper (point 46) appears to allow point of sale (POS) displays; children may get substantial exposure to POS displays in dairies (retail outlets many visit quite frequently).
"Smokers are not the only people who will see these displays and there is not enough detail as to how point 45 (advertising should not encourage non-smokers, including children and young people, to vape as nicotine is addictive and vaping is not completely without risk to health and wellbeing) will ensure children are protected from e-cigarette marketing.
"Overseas examples of e-cigarette marketing suggest these have used provocative themes likely to appeal to young people; there needs to be more detail about how the marketing activities seen internationally will be regulated in New Zealand to prevent these promotions from encouraging uptake among children and young people.
"There is already high awareness of e-cigarettes, so the reasoning underlying point 44 (Smokers need to be able to see what is available if they are to be encouraged to switch) is not clear.
"Smokers would seem more likely to switch from smoking to vaping, if they get expert advice, and it is not clear how dairies, supermarkets or service stations are set up to provide such advice.
"Specialist vape stores and pharmacies would seem better positioned to provide expert guidance."
Professor Tony Blakely, Department of Public Health, University of Otago, comments:
"This announcement by the Government is sensible. In particular, the cautious approach to applying the same restrictions to the sale and marketing of e-cigarettes as currently apply for tobacco.
"E-cigarettes are almost certainly (far) less health damaging that tobacco to humans – at least among people who ‘have to keep using either tobacco or e-cigarettes’.
"However, uncertainty remains about many important aspects of long-term used, to both individuals and the population. Namely:
• E-cigarettes vary enormously in the chemicals they contain. There will be some health harm – much less in all likelihood than tobacco. However, the exact health harm is unknown. Moreover, we will need long-term follow-up studies in addition to toxicology studies on how different e-cigarettes have different harm profiles depending on the chemicals and nature of the device.
• E-cigarettes probably increase the chance of someone quitting tobacco altogether, but the exact benefit as a cessation aid needs clarification.
• If someone elects to use both e-cigarettes (e.g. when out with friends) and smoke tobacco (e.g. when by themselves) then probably the health damage to them is less than if they continue to smoke tobacco only.
• But a big uncertainty is the potential unintended consequences at the population level. At the level of population norms and culture. There is a real risk that e-cigarettes may actually assist re-normalise smoking, slowing down quit rates in the future as ‘some form of nicotine use’ is renormalised and ‘accepted’. We do not know how much of an issue this is.
• It may be better for population health if e-cigarettes were less like tobacco cigarettes, and more like (say) an aerosol, so as to reduce the risk or re-normalising cigarette smoking itself.
For all these reasons, a cautious approach to the legalisation of e-cigarettes is required. Ongoing research and monitoring is required. And an ongoing ability to strictly control their sale (e.g. licensed outlets only) has to be considered, in tandem with controls on tobacco."